Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.
To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.
Please help improve GET-Evidence by evaluating evidence for this variant!
You are viewing an old version of this page that was saved on November 27, 2013 at 8:30am by Madeleine Ball.
Insufficiently evaluated pathogenic
(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)
Summary of published research, and additional commentary
Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, Raue F,
Ritter MM, Höppner W. A new hot spot for mutations in the ret protooncogene
causing familial medullary thyroid carcinoma and multiple endocrine neoplasia
type 2A. J Clin Endocrinol Metab. 1998 Mar;83(3):770-4. PubMed PMID: 9506724.
Added in this revision:
Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J,
Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T,
Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M,
Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C,
Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations
in nonsyndromic pheochromocytoma. N Engl J Med. 2002 May 9;346(19):1459-66.
PubMed PMID: 12000816.